CERTAIN INFORMATION IN THIS EXHIBIT IDENTIFIED BY [*****] IS CONFIDENTIAL AND HAS BEEN EXCLUDED BECAUSE THE REGISTRANT ACTUALLY TREATS THAT INFORMATION AS CONFIDENTIAL] REVENUE INTEREST PURCHASE AGREEMENT dated as of December 29, 2023 among...Revenue Interest Purchase Agreement • March 19th, 2024 • ImmunityBio, Inc. • Biological products, (no disgnostic substances) • New York
This REVENUE INTEREST PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of December 29, 2023, by and among ImmunityBio, Inc., a Delaware corporation (the “Company”), the Purchasers from time to time party hereto (each, a “Purchaser” and collectively, the “Purchasers”) and Infinity SA LLC, as collateral agent and administrative agent for the Purchasers (the “Purchaser Agent”).
October 3, 2023 Duley Road, LLCImmunityBio, Inc. • March 19th, 2024 • Biological products, (no disgnostic substances)
ContractSubordination Agreement • March 19th, 2024 • ImmunityBio, Inc. • Biological products, (no disgnostic substances) • California
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
SECURITY AND PLEDGE AGREEMENTSecurity and Pledge Agreement • March 19th, 2024 • ImmunityBio, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECURITY AND PLEDGE AGREEMENT (this “Agreement”) is entered into as of December 29, 2023 among ImmunityBio, Inc., a Delaware corporation (the “Company”), the Subsidiary Guarantors listed on the signature pages hereto, such other parties that may become Grantors hereunder after the date hereof (together with the Company and the Subsidiary Guarantors, each individually a “Grantor”, and collectively, the “Grantors”) and Infinity SA LLC, a Delaware limited liability company, in its capacity as agent (in such capacity, the “Purchaser Agent”) for the Secured Parties.
STOCK PURCHASE AND OPTION AGREEMENTStock Purchase and Option Agreement • March 19th, 2024 • ImmunityBio, Inc. • Biological products, (no disgnostic substances) • New York
This STOCK PURCHASE AND OPTION AGREEMENT (this “Agreement”), is made and entered as of December 29, 2023 (the “Execution Date”), by and between (i) TPC INVESTMENTS II LP, a Delaware limited partnership, TPC INVESTMENTS III LP, a Delaware limited partnership, TPC INVESTMENTS SOLUTIONS LLC, a Delaware limited liability company, and TPC INVESTMENTS SOLUTIONS CO-INVEST LP, a Delaware limited partnership, (each, an “Investor” and collectively, the “Investors”) and (ii) IMMUNITYBIO, INC., a Delaware corporation (the “Company”). The Investors and the Company are referred to herein, collectively, as the “Parties” and each, individually, as a “Party”.
